US Stock MarketDetailed Quotes

BEAM Beam Therapeutics

Watchlist

29.010
+2.160+8.04%

Close Dec 20 16:00 ET

29.031
+0.021+0.07%

Post 20:01 ET

2.40BMarket Cap-18.36P/E (TTM)

Beam Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Beam Therapeutics Q3 2024 Earnings Date

Currency：USDNov 5, 2024

	Estimate (YoY)	Actual (YoY)	Vs Estimate (% Chg)
Revenue	14.13M	14.27M	+137.03K
Beat Est.	-17.80%	-17.01%	+0.97%
EPS	-1.15	-1.17	-0.02
Miss Est.	+6.12%	+4.10%	-2.17%

Analyst Rating

Buy

Dec 22, 2024

Beam Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 13.461M	--
--	2024/Q4	-- / 15.551M	--
Nov 5, 2024	2024/Q3	14.269M / 14.132M	--
--	2024/Q2	11.772M / 13.047M	--
--	2024/Q1	7.410M / 14.664M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 13.461M--

--2024/Q4-- / 15.551M--

Nov 5, 20242024/Q314.269M / 14.132M--

--2024/Q211.772M / 13.047M--

--2024/Q17.410M / 14.664M--

Unlock Free Earnings Estimates

Open Account

Beam Therapeutics Earnings Reports

Beam Therapeutics | 10-Q: Q3 2024 Earnings Report

Nov 5 09:11 ET

Beam Therapeutics | 8-K: Beam Therapeutics Reports Third Quarter 2024 Financial Results and Progress Across Priority Programs

Nov 5 07:06 ET

Beam Therapeutics | 10-Q: Q2 2024 Earnings Report

Aug 6 08:58 ET

Beam Therapeutics | 8-K: Beam Therapeutics Reports Pipeline Updates and Second Quarter 2024 Financial Results

Aug 6 07:13 ET

Trending US Stocks

Symbol Mini Chart % Chg

Unlock the Full List

Analysis

Analyst Rating

Updated: Dec 22, 2024

Buy

Buy
71.43%
Hold
28.57%
Sell
0.00%

Price Target

No Data